BFM Podcast
疫苗红利变毒药 马股制药一哥发马陷入巨亏困境
09-Mar-23 16:20
发马是我国最大的制药公司，同时也是马股里的第一股，公司在2020年因为获得科兴疫苗独家的经销权，公司股价从最低的20仙令吉，一度飙升到1.14令吉，成为在疫情时代中少数的大赢家。然而，在后疫情时代里，疫苗需求大幅衰退，公司也面临巨额亏损的问题，到底这家公司何去何从？今天市场追踪，让我们持续关注，这家公司的发展。
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
Market Buzz
2023-05-23
2023-05-23
2023-05-22
More articles on BFM Podcast
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Trending Events
Apps
Top Articles
1
2
Good Articles to Share
Experts issue warning as Social Security’s ‘day of reckoning’ inches closer
3
Good Articles to Share
4
Good Articles to Share
At least 3 mln Tunisians face food insecurity threat: agency
5
Good Articles to Share
6
Good Articles to Share
Tens of thousands in Serbia protest mass shootings, government policies
7
Good Articles to Share
8
Good Articles to Share
Turkey's Erdogan urges voters to turn out, rival sees 'last exit'
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
